GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Total Operating Expense

AZN (AstraZeneca) Total Operating Expense : $34,190 Mil (TTM As of Mar. 2025)


View and export this data going back to 1993. Start your Free Trial

What is AstraZeneca Total Operating Expense?

AstraZeneca's Total Operating Expense for the three months ended in Mar. 2025 was $7,673 Mil. AstraZeneca's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $34,190 Mil.

AstraZeneca Total Operating Expense Historical Data

The historical data trend for AstraZeneca's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Total Operating Expense Chart

AstraZeneca Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,402.00 25,119.00 27,448.00 28,821.00 33,615.00

AstraZeneca Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,346.00 8,009.00 8,378.00 10,130.00 7,673.00

AstraZeneca Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $34,190 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca Total Operating Expense Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (NAS:AZN) » Definitions » Total Operating Expense
Comparable Companies
LSE:GSK LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN MRK AMGN PFE GILD XPAR:SAN BMY TSE:4519 TSE:4568 SHSE:600276 XTER:BAYN TSE:4578 BIIB TSE:4503
Traded in Other Exchanges
AZNCF:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany A1ZN34:Brazil AZNA:Austria AZN:Argentina
Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
Website
https://www.astrazeneca.com
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.